Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Life Sciences|February 21, 2018
Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myelomaYing Shen, Yuandong Feng, Hongli Chen, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 4, 2018
Circ-ANAPC7 is Upregulated in Acute Myeloid Leukemia and Appears to Target the MiR-181 FamilyHongli Chen, Tian Liu, Jing Liu, et al.Medicina Clinica|January 3, 2018
Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemiaYing Shen, Aili He, Fangxia Wang, et al.Cancer Science|December 9, 2017
Expression profile analysis of long non-coding RNA in acute myeloid leukemia by microarray and bioinformaticsYuandong Feng, Ying Shen, Hongli Chen, et al.Hemasphere|November 20, 2024
The incidence and clinical significance of monoclonal and oligoclonal protein bands in multiple myeloma patients after BCMA-CAR-T cell therapy: A retrospective study based on LEGEND-2Rui Liu, Gongzhizi Gao, Hongli Chen, et al.Frontiers in Oncology|July 9, 2024
Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patientsYuxin Li, Yilin Zhang, Jin Wang, et al.Frontiers of Medicine|October 2, 2019
Management of cytokine release syndrome related to CAR-T cell therapyHongli Chen, Fangxia Wang, Pengyu Zhang, et al.Journal of Cancer|October 30, 2020
MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemiaBo Lei, Lu Qian, Yanping Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)Jian-Qing Mi, Wanhong Zhao, Hongmei Jing, et al.Experimental Hematology & Oncology|July 27, 2023
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic eraTingting Zhang, Weiwei Tian, Shuang Wei, et al.Pageof 3